AMS  Clinical Research Teams & Indications

Indication-specialized teams will take care:

As part of the AMS company philosophy, indication-specialized teams are set up to strengthen special therapeutic experience across all areas of the Clinical Research services provided.
The AMS Clinical Research team includes experienced physicians who continuously support all projects in multiple aspects of project performance, such as:

  • Clinical trial design
  • Protocol set-up
  • Site and patient selection
  • Medical review
  • Medical input to final report

Our specialized teams have broad experience in various specific indications from a large number of trials conducted at AMS. To ensure the most recent and in-depth knowledge of highly specific indications and study procedures, our study teams and clinical research associates are regularly trained.

Please find AMS' Clinical Research Indication Experience here.

Get in touch with us at:

Your direct Contact:

lightviolett

Kathryn Hutchinson

Director Regulatory Affairs
mailto:
green

Harald Wagner

Director Clinical Operations
mailto:
lightturquose

Frank Scherer

Director Biostatistics
mailto: Biostatistics
green

Hassan Kazerooni

Director Data Management
mailto:
lightturquose

Marianne Diers-Fenger

Director Clinical Safety
mailto:
green

Iris Czerwenka

Director Medical Writing
mailto:

• 2011 – AMS AMNOG Services pioneer • 2013 – AMS-Investigator SELF-TRAINING PORTAL • 2013 – “BEST CRO” by one of ther world’s Top 5 Pharma companies’ CRO Evaluation for AMS – Clinical Operations Services • 2014 – AMS performs Medical App Studies including eCRF-data integration • 2015 – AMS Medical Science is awarded “Provider of the Year, worldwide” the world’s Top 10 Pharma companies • 2015 – AMS develops an E-feasibility tool • 2015 – Innovative Tool for Patient Reported Outcomes: AMS-ePRO (BYOD-type PRO solution) is developed • 2016 – AMS – Regulatory Affairs is nominated on the short-list for TOPRA Award for Regulatory Excellence

News